166 related articles for article (PubMed ID: 29334279)
21. The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.
Thakkar SG; Ruwona TB; Williams RO; Cui Z
Hum Vaccin Immunother; 2017 Apr; 13(4):936-946. PubMed ID: 28051903
[TBL] [Abstract][Full Text] [Related]
22. Comparison of adjuvant and adjuvant-free murine experimental asthma models.
Conrad ML; Yildirim AO; Sonar SS; Kiliç A; Sudowe S; Lunow M; Teich R; Renz H; Garn H
Clin Exp Allergy; 2009 Aug; 39(8):1246-54. PubMed ID: 19438585
[TBL] [Abstract][Full Text] [Related]
23. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection.
Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A
Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340
[TBL] [Abstract][Full Text] [Related]
24. Intraperitoneal administration of aluminium-based adjuvants produces severe transient systemic adverse events in mice.
Freiberger SN; Leuthard DS; Duda A; Contassot E; Thallmair M; Kündig TM; Johansen P
Eur J Pharm Sci; 2018 Mar; 115():362-368. PubMed ID: 29410031
[TBL] [Abstract][Full Text] [Related]
25. Nanoalum adjuvanted vaccines: small details make a big difference.
Raponi A; Brewer JM; Garside P; Laera D
Semin Immunol; 2021 Aug; 56():101544. PubMed ID: 34895823
[TBL] [Abstract][Full Text] [Related]
26. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
[TBL] [Abstract][Full Text] [Related]
27. Parenteral adjuvant potential of recombinant B subunit of Escherichia coli heat-labile enterotoxin.
Cunha CEPD; Moreira C; Rocha ADSR; Finger PF; Magalhães CG; Ferreira MRA; Dellagostin OA; Moreira ÂN; Conceição FR
Mem Inst Oswaldo Cruz; 2017 Dec; 112(12):812-816. PubMed ID: 29211241
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles.
Lebre F; Pedroso de Lima MC; Lavelle EC; Borges O
Int J Pharm; 2018 Dec; 552(1-2):7-15. PubMed ID: 30244149
[TBL] [Abstract][Full Text] [Related]
29. Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease.
Petrasek J; Iracheta-Vellve A; Saha B; Satishchandran A; Kodys K; Fitzgerald KA; Kurt-Jones EA; Szabo G
J Leukoc Biol; 2015 Aug; 98(2):249-56. PubMed ID: 25934928
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
31. Structural perturbation of diphtheria toxoid upon adsorption to aluminium hydroxide adjuvant.
Régnier M; Metz B; Tilstra W; Hendriksen C; Jiskoot W; Norde W; Kersten G
Vaccine; 2012 Nov; 30(48):6783-8. PubMed ID: 23000120
[TBL] [Abstract][Full Text] [Related]
32. Stabilised aluminium phosphate nanoparticles used as vaccine adjuvant.
Vrieling H; Espitia Ballestas M; Hamzink M; Willems GJ; Soema P; Jiskoot W; Kersten G; Metz B
Colloids Surf B Biointerfaces; 2019 Sep; 181():648-656. PubMed ID: 31212137
[TBL] [Abstract][Full Text] [Related]
33. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.
Hansen B; Sokolovska A; HogenEsch H; Hem SL
Vaccine; 2007 Sep; 25(36):6618-24. PubMed ID: 17681647
[TBL] [Abstract][Full Text] [Related]
34. Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant.
Dillon SB; Demuth SG; Schneider MA; Weston CB; Jones CS; Young JF; Scott M; Bhatnaghar PK; LoCastro S; Hanna N
Vaccine; 1992; 10(5):309-18. PubMed ID: 1349448
[TBL] [Abstract][Full Text] [Related]
35. The role of uric acid as an endogenous danger signal in immunity and inflammation.
Ghaemi-Oskouie F; Shi Y
Curr Rheumatol Rep; 2011 Apr; 13(2):160-6. PubMed ID: 21234729
[TBL] [Abstract][Full Text] [Related]
36. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
[TBL] [Abstract][Full Text] [Related]
37. Aluminium hydroxide potentiates a protective Th1 biased immune response against polio virus that allows for dose sparing in mice and rats.
Andreasen LV; Hansen LB; Andersen P; Agger EM; Dietrich J
Vaccine; 2015 Apr; 33(15):1873-9. PubMed ID: 25698487
[TBL] [Abstract][Full Text] [Related]
38. A serological comparison of Pasteurella haemolytica vaccines containing different adjuvants.
Wells PW; Gilmour NJ; Burrells C; Thompson DA
Res Vet Sci; 1979 Sep; 27(2):248-50. PubMed ID: 523817
[TBL] [Abstract][Full Text] [Related]
39. Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles.
Toda T; Yoshino S
Int J Immunopathol Pharmacol; 2016 Sep; 29(3):408-20. PubMed ID: 27343242
[TBL] [Abstract][Full Text] [Related]
40. Crystalline and Amorphous Preparation of Aluminum Hydroxide Nanoparticles Enhances Protective Antigen Domain 4 Specific Immunogenicity and Provides Protection Against Anthrax.
Gogoi H; Mani R; Aggarwal S; Malik A; Munde M; Bhatnagar R
Int J Nanomedicine; 2020; 15():239-252. PubMed ID: 32021177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
